Yosef Rubinstein

Title: Innovations in Transdermal Administration by Yosef Rubinstein

Introduction

Yosef Rubinstein is a notable inventor based in Nes Ziona, Israel. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of transdermal administration. With a total of five patents to his name, Rubinstein's work focuses on enhancing the delivery of therapeutically active proteins and polypeptides.

Latest Patents

Rubinstein's latest patents include formulations that comprise therapeutically active proteins or polypeptides. One of his notable inventions is a pharmaceutical formulation specifically designed for transdermal administration. This formulation includes an aqueous emulsion or dispersion that contains an active ingredient, at least one therapeutically active protein or polypeptide, and a pharmaceutically acceptable emulsifier. The formulation is designed to ensure that the therapeutic activity of the active ingredient is detectable in the bloodstream within less than two hours after administration. Another significant patent involves a pharmaceutical composition for transdermal administration to both humans and animals. This composition includes an effective amount of a medicament adapted for transdermal delivery and a carrier selected from semisolids and liquids at ambient temperatures.

Career Highlights

Throughout his career, Rubinstein has worked with various companies, including Dermamed, Inc. and Pharmaderm Research & Development Ltd. His expertise in pharmaceutical formulations has positioned him as a key figure in the development of innovative transdermal delivery systems.

Collaborations

Rubinstein has collaborated with Avi Gertner, contributing to advancements in the field of transdermal administration.

Conclusion

Yosef Rubinstein's innovative work in transdermal administration has the potential to significantly impact the pharmaceutical industry. His patents reflect a commitment to improving the efficacy of drug delivery systems.